Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Buys $20,998.57 in Stock

Key Points

• CEO Dagi Ben-Noon purchased 14,093 shares of Inspira Technologies at an average price of $1.49, investing $20,998.57. This follows additional purchases totaling nearly $150,000 in late September and early October.
• QTEX shares rose 1.6% to $1.60 during Tuesday trading, while the company reported a quarterly loss of $0.07 per share on $0.78 million in revenue.
• Analyst sentiment remains negative: the stock has a consensus “Sell” rating, despite the company’s approval of a buyback program covering up to 5.6% of outstanding shares.

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX - Get Free Report) CEO Dagi Ben-Noon purchased 14,093 shares of the business's stock in a transaction on Tuesday, October 13th. The stock was acquired at an average price of $1.49 per share, with a total value of $20,998.57. Following the completion of the acquisition, the chief executive officer directly owned 14,093 shares in the company, valued at $20,998.57. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Friday, October 9th, Dagi Ben-Noon bought 18,181 shares of Inspira Technologies OXY B.H.N. stock. The stock was acquired at an average price of $1.67 per share, with a total value of $30,362.27.
• On Monday, September 28th, Dagi Ben-Noon bought 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were acquired at an average price of $0.71 per share, for a total transaction of $119,914.74.

Inspira Technologies OXY B.H.N. Stock Up 1.6%

NASDAQ:QTEX traded up $0.03 during mid-day trading on Tuesday, reaching $1.60. The company's stock had a trading volume of 6,279,581 shares, compared to its average volume of 12,422,833. The stock's fifty day moving average price is $0.97. The company has a current ratio of 2.00, a quick ratio of 1.62 and a debt-to-equity ratio of 0.12. Inspira Technologies OXY B.H.N. Ltd has a twelve month low of $0.28 and a twelve month high of $3.85.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX - Get Free Report) last posted its quarterly earnings data on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has approved a stock repurchase program on Monday, June 22nd that authorizes the company to repurchase 2,000,000,000,000 outstanding shares. This buyback authorization authorizes the company to purchase up to 5.6% of its shares through open market purchases. Share buyback programs are generally an indication that the company's board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Wall Street Zen lowered shares of Inspira Technologies OXY B.H.N. from a "hold" rating to a "sell" rating in a report on Saturday, August 8th. Weiss Ratings downgraded Inspira Technologies OXY B.H.N. from a "sell (d-)" rating to a "sell (e+)" rating in a report on Friday. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company currently has a consensus rating of "Sell".

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company's technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.